NCT00000725View on ClinicalTrials.gov

A Phase I Study of AZT and Human Interferon Alpha (Recombinant Alpha-2A and Lymphoblastoid) in the Treatment of AIDS-Associated Kaposi's Sarcoma

PHASE1CompletedINTERVENTIONAL

Enrollment

56

Participants

Timeline

Start Date

Not specified

Study Completion Date

February 28, 1990

Conditions

Sarcoma, KaposiHIV Infections

Interventions

DRUG

Interferon alfa-2a

DRUG

Zidovudine

DRUG

Interferon alfa-n1

Trial Locations (1)

331361013

Univ of Miami School of Medicine, Miami

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH